证券之星消息，10月22日动物保健板块较上一交易日下跌0.36%，大禹生物领跌。当日上证指数报收于 3913.76，下跌0.07%。深证成指报收于12996.61，下跌0.62%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600201 | 生物股份 | 10.78 | 0.56% | 32.70万 | 3.51亿 | | 300119 | 瑞普生物 | 21.50 | 0.51% | 7.32万 | 1.58亿 | | 603718 | 海利生物 | 7.04 | 0.28% | 4.42万 | 3116.99万 | | 603566 | 音菜柯 > | 14.01 | -0.07% | 2.79万 | 3927.61万 | | 600195 | 中牧股份 | 7.41 | -0.40% | 6.46万 | 4813.05万 | | 920729 | 永顺生物 | 9.83 | -0.61% | 2.44万 | 2390.23万 | | 688098 | 申联 ...

Core Viewpoint - The animal health sector experienced a slight decline of 0.02% on October 21, with Bioworks leading the drop. Meanwhile, the Shanghai Composite Index rose by 1.36% and the Shenzhen Component Index increased by 2.06% [1]. Group 1: Market Performance - The animal health sector's performance was mixed, with individual stocks showing varying degrees of increase and decrease. Notably, the top gainers included: - Driving Force (4.50% increase) [1] - Dayu Biological (3.46% increase) [1] - Yongshun Biological (2.06% increase) [1] - Conversely, Bioworks saw a decline of 2.10%, leading the losses in the sector [2]. Group 2: Trading Volume and Capital Flow - The trading volume for the animal health sector indicated a net outflow of 151 million yuan from institutional investors, while retail investors saw a net inflow of 116 million yuan [2]. - The capital flow for individual stocks showed significant movements, with: - Key stock, Bioworks, experiencing a net outflow of 6.46 million yuan from institutional investors [3]. - Retail investors contributed a net inflow of 7.59 million yuan to Zhongmu Co. [3]. Group 3: Individual Stock Analysis - The following stocks had notable capital flows: - KQ Biological had a net inflow of 1.83 million yuan from institutional investors [3]. - ST Green Health faced a net outflow of 4.37 million yuan from institutional investors [3]. - The stock of Rui Pu Biological saw a net inflow of 17.22 million yuan from retail investors despite a net outflow from institutional investors [3].

Market Overview - The animal health sector increased by 0.81% on October 20, with Xianfeng Holdings leading the gains [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Stock Performance - Xianfeng Holdings (002141) closed at 4.06, up 5.45% with a trading volume of 588,700 shares and a turnover of 237 million yuan [1] - Other notable stocks included ST Lvkang (002868) at 28.36, up 5.00%, and Biological Shares (600201) at 10.95, up 1.48% [1] - The overall trading volume and turnover for the animal health sector were significant, indicating active market participation [1] Capital Flow - The animal health sector saw a net inflow of 31.5863 million yuan from institutional investors, while retail investors experienced a net outflow of 10.9434 million yuan [2] - The main capital inflow was primarily directed towards Xianfeng Holdings, which had a net inflow of 28.5381 million yuan [3] - Conversely, stocks like Shunlian Biological (688088) and ST Lvkang experienced net outflows from retail investors, indicating a shift in investor sentiment [3]

Market Overview - The Shanghai Composite Index closed at 3839.76 points, below the five-day moving average, with a decline of 1.95% [1] - The total trading volume of A-shares reached 1,954.408 billion yuan [1] Stocks Performance - A total of 152 A-shares broke through the five-day moving average today [1] - Stocks with significant deviation rates include: - Haixia Innovation (14.94%) - Shenlian Biology (8.07%) - Huabang Health (7.93%) [1] - Stocks with minor deviation rates that just crossed the five-day moving average include Tianyu Co., Suhao Fashion, and Longquan Co. [1] Notable Stocks - Top stocks with the highest deviation rates on October 17: - Haixia Innovation: +19.96% with a turnover rate of 18.39%, five-day moving average at 5.07 yuan, latest price at 5.83 yuan [1] - Shenlian Biology: +10.65% with a turnover rate of 7.78%, five-day moving average at 10.58 yuan, latest price at 11.43 yuan [1] - Huabang Health: +10.11% with a turnover rate of 8.30%, five-day moving average at 4.64 yuan, latest price at 5.01 yuan [1]

Core Viewpoint - The innovative drug concept stocks continue to be active, with significant gains observed in several companies [2] Company Performance - Huabang Health reached the daily limit increase in stock price [2] - Other companies such as Shenlian Bio, Shutaishen, Chenxin Pharmaceutical, Weikang Pharmaceutical, and Hite Bio also experienced upward movement in their stock prices [2]

Core Viewpoint - The animal health sector experienced a decline of 0.85% on October 16, with Xianfeng Holdings leading the drop. The Shanghai Composite Index rose by 0.1%, while the Shenzhen Component Index fell by 0.25 [1]. Group 1: Market Performance - The closing price of *ST Lvkang was 27.48, with an increase of 5.01%, while other stocks in the sector showed mixed results [1]. - The total trading volume for the animal health sector was significant, with *ST Lvkang recording a volume of 14,900 hands and a transaction amount of 40.81 million yuan [1]. - The overall market saw a net outflow of 126 million yuan from the animal health sector, with retail investors contributing a net inflow of 91.62 million yuan [2]. Group 2: Individual Stock Analysis - *ST Lvkang had a net inflow of 5.23 million yuan from major funds, while Xianfeng Holdings saw a net outflow of 3.36 million yuan [3]. - The stock of RuiPu Bio had a significant net outflow of 25.44 million yuan from major funds, despite a retail net inflow of 39.62 million yuan [3]. - The stock of HaiLi Bio experienced a net outflow of 4.47 million yuan from major funds, with a retail net inflow of 2.64 million yuan [3].

Core Insights - The animal health sector experienced a 1.5% increase on October 15, with Bio-Pharmaceuticals leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Stock Performance - Bio-Pharmaceuticals (600201) closed at 11.03, up 4.06% with a trading volume of 563,500 shares and a turnover of 614 million yuan [1] - Other notable stocks include: - Shunlian Bio (688098) at 10.48, up 2.95% [1] - Ruipu Bio (300119) at 22.56, up 2.31% [1] - Yongshun Bio (920729) at 676, up 1.93% [1] - Dayu Bio (920970) at 9.45, up 1.61% [1] Capital Flow - The animal health sector saw a net outflow of 5.71 million yuan from institutional investors, while retail investors contributed a net inflow of 1.83 million yuan [2] - The capital flow for key stocks includes: - Ruipu Bio had a net inflow of 25.55 million yuan from institutional investors [3] - Hai Li Bio experienced a net outflow of 3.22 million yuan from institutional investors [3] - KQ Bio (688526) had a net inflow of 5.26 million yuan from retail investors [3]

Core Viewpoint - The animal health sector experienced a decline of 0.68% on October 14, with Xianfeng Holdings leading the drop. The Shanghai Composite Index closed at 3865.23, down 0.62%, while the Shenzhen Component Index closed at 12895.11, down 2.54% [1]. Stock Performance Summary - Zhongmu Co., Ltd. (600195) closed at 7.35, up 1.66% with a trading volume of 120,000 shares and a transaction value of 87.91 million yuan [1]. - Yongshun Biological (920729) closed at 9.31, up 0.54% with a trading volume of 13,800 shares and a transaction value of 12.82 million yuan [1]. - Biological Co. (600201) closed at 10.60, up 0.28% with a trading volume of 624,200 shares and a transaction value of 672 million yuan [1]. - Other notable stocks include Ruip Bio (300119) down 0.45% and Jinhai Bio (002688) down 0.98% [1][2]. Capital Flow Analysis - The animal health sector saw a net outflow of 8.12 million yuan from institutional investors, while retail investors had a net inflow of 4.61 million yuan [2][3]. - Major stocks like Biological Co. (600201) experienced a net inflow of 62.91 million yuan from institutional investors, while Xianfeng Holdings (002141) saw a net outflow of 9.04 million yuan [3].

Core Insights - The animal health sector experienced a rise of 1.98% on October 10, with Bio-Pharmaceuticals leading the gains [1] - The Shanghai Composite Index closed at 3897.03, down 0.94%, while the Shenzhen Component Index closed at 13355.42, down 2.7% [1] Stock Performance - Bio-Pharmaceuticals (600201) closed at 10.16, up 4.42% with a trading volume of 808,300 shares and a transaction value of 815 million [1] - Other notable performers included: - Houbang Holdings (002141) at 3.85, up 3.77% [1] - Ruipu Biological (300119) at 21.87, up 3.16% [1] - Dayu Biological (920970) at 66.6, up 2.62% [1] - Huisheng Biological (300871) at 21.33, up 2.06% [1] Capital Flow - The animal health sector saw a net inflow of 111 million from institutional investors, while retail investors experienced a net outflow of 96.24 million [2] - The capital flow for key stocks included: - Bio-Pharmaceuticals (600201) with a net inflow of 73.87 million from institutional investors [3] - Huisheng Biological (300871) with a net inflow of 17.64 million from institutional investors [3] - Houbang Holdings (002141) with a net inflow of 16.38 million from institutional investors [3]

Core Insights - The animal health sector experienced a slight increase of 0.01% on October 9, with the leading stock being Driveline [1] - The Shanghai Composite Index closed at 3933.97, up 1.32%, while the Shenzhen Component Index closed at 13725.56, up 1.47% [1] Stock Performance - Driveline (920275) closed at 9.57, up 1.38%, with a trading volume of 17,600 and a turnover of 11.63 million [1] - Jinhai Biological (002688) closed at 6.77, up 1.20%, with a trading volume of 183,400 and a turnover of 123 million [1] - Biological Shares (600201) closed at 9.73, up 0.93%, with a trading volume of 470,500 [1] - Huisheng Biological (300871) closed at 20.90, up 0.87%, with a trading volume of 41,600 [1] - Other notable stocks include Plai Ke (603566) at 13.82, up 0.58%, and Haili Biological (603718) at 6.81, up 0.15% [1] Capital Flow - The animal health sector saw a net outflow of 53.09 million from institutional investors, while retail investors had a net inflow of 28.12 million [2] - The total net inflow from speculative funds was 24.97 million [2] Individual Stock Capital Flow - Ruipu Biological (300119) had a net inflow of 7.31 million from institutional investors, while it experienced a net outflow of 9.14 million from retail investors [3] - Plai Ke (603566) saw a net inflow of 2.41 million from institutional investors but a net outflow of 6.28 million from retail investors [3] - Other stocks like *ST Green Kang (002868) and Jinhai Biological (002688) experienced significant net outflows from institutional investors [3]